Anna Barkaway, PhD, has a strong background in immunology and medical research, complemented by experience in medical affairs. At University of Reading, Anna served as a Student Ambassador from October 2012 to July 2014, promoting the university through various educational events. Anna obtained a PhD from Barts and The London School of Medicine and Dentistry between 2015 and 2019, focusing on the impact of age on neutrophil-vessel wall interactions. Following this, Anna worked as a Postdoctoral Research Scientist at The William Harvey Research Institute, leading significant research with findings published in a high-impact journal. In a Research Fellow position at University College London from March 2021 to June 2022, Anna studied leukocyte-vascular interactions in neurological diseases. Currently, Anna is involved in medical affairs at Pfizer, serving a variety of roles including Rheumatology Medical Affairs Manager. Academic credentials include a First Class Honours degree in Biochemistry from University of Reading and an MRes in Inflammation from Barts and The London School of Medicine and Dentistry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices